MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

Ray Blanco on MYMD-1

Blanco tells us what most of us got from the last press release, but adds that if MYMD-1 gets just an eighth of the $40 billion market for TNF-alpha blockers, the possible gain exceeds 10,000% from the current price of the stock.

He sees a "huge catalyst" when the company reports Phase 2 results in mid-2022.

(I wrote a much longer summary but iHub spontaneously erased it and required me to start over. No time left.)